$6.77
0.000.00%
al cierre: -
$6.90
0.131.92%
After hour: 5:34 PM EDT
Comments
Loading...
Orientación y previsiones
Bioventus emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/06/2025 | BVS | Bioventus | FY | 2025 | $0.64 | $0.68 | $0.66 | $560.00M | $570.00M | $565.82M | |
05/06/2025 | BVS | Bioventus | FY | 2025 | $0.64 | $0.68 | $0.66 | $560.00M | $570.00M | $564.86M | |
03/11/2025 | BVS | Bioventus | FY | 2025 | $0.64 | $0.68 | $0.55 | $560.00M | $570.00M | $554.78M | |
11/05/2024 | BVS | Bioventus | FY | 2024 | $0.40 | $0.42 | $0.39 | $562.00M | $567.00M | $561.77M | |
08/06/2024 | BVS | Bioventus | FY | 2024 | $0.36 | $0.42 | $0.28 | $557.00M | $567.00M | $542.77M | |
05/07/2024 | BVS | Bioventus | FY | 2024 | $0.25 | $0.33 | $0.16 | $535.00M | $550.00M | $528.03M | |
03/12/2024 | BVS | Bioventus | FY | 2024 | $0.12 | $0.20 | $0.33 | $520.00M | $535.00M | $517.82M | |
11/07/2023 | BVS | Bioventus | FY | 2023 | -$0.12 | -$0.09 | -$0.19 | $498.00M | $505.00M | $499.79M | |
08/08/2023 | BVS | Bioventus | FY | 2023 | -$0.24 | -$0.20 | -$0.22 | $490.00M | $505.00M | $493.14M | |
11/21/2022 | BVS | Bioventus | FY | 2022 | $0.20 | $0.25 | $0.26 | $517.00M | $522.00M | $530.25M | |
11/08/2022 | BVS | Bioventus | FY | 2022 | $0.20 | $0.25 | $0.51 | $527.00M | $532.00M | $553.86M | |
08/11/2022 | BVS | Bioventus | FY | 2022 | $0.47 | $0.57 | $0.65 | $547.50M | $562.50M | $552.13M | |
05/10/2022 | BVS | Bioventus | FY | 2022 | — | — | — | $545.00M | $565.00M | $553.75M | |
05/03/2022 | BVS | Bioventus | FY | 2022 | — | — | — | $545.00M | $565.00M | $553.75M | |
04/26/2022 | BVS | Bioventus | Q1 | 2022 | — | — | — | $116.50M | $118.50M | $117.76M | |
03/10/2022 | BVS | Bioventus | FY | 2022 | — | — | — | $545.00M | $565.00M | $558.52M | |
01/11/2022 | BVS | Bioventus | Q4 | 2021 | — | — | — | $128.50M | $131.50M | $124.56M | |
01/11/2022 | BVS | Bioventus | FY | 2021 | — | — | — | $429.00M | $432.00M | $429.33M | |
11/09/2021 | BVS | Bioventus | FY | 2021 | — | — | — | $425.00M | $430.00M | $410.24M | |
08/10/2021 | BVS | Bioventus | FY | 2021 | — | — | — | $405.00M | $415.00M | $400.94M | |
07/29/2021 | BVS | Bioventus | Q2 | 2021 | — | — | — | $108.00M | $110.00M | $102.62M | |
07/29/2021 | BVS | Bioventus | FY | 2021 | — | — | — | $405.00M | $415.00M | $400.94M | |
05/12/2021 | BVS | Bioventus | FY | 2021 | — | — | — | $394.00M | $406.00M | $381.54M | |
03/25/2021 | BVS | Bioventus | FY | 2021 | — | — | — | $360.00M | $372.00M | $364.48M |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de Bioventus (BVS)?
La orientación más reciente para Bioventus (BVS) se informó el agosto 6, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $0.64 a $0.68, en comparación con el EPS estimado de $0.66. Además, Bioventus pronosticó ingresos entre $0.56B y $0.57B para el trimestre.
Explora orientación y previsión sobre todos los valores.